Abstract:Introduction The surgical intervention approach to insulinomas in proximity to the main pancreatic duct remains controversial. Standard pancreatic resection is recommended by several guidelines; however, enucleation (EN) still attracts surgeons with less risk of late exocrine/endocrine insufficiency, despite a higher postoperative pancreatic fistula (POPF) rate. Recently, the efficacy and safety of preoperative pancreatic stent placement before the EN have been demonstrated. Thus, a multicentre open-label study is being conducted to evaluate the efficacy and safety of stent placement in improving the outcome of EN of insulinomas in proximity to the main pancreatic duct. Methods and analysis This is a prospective, randomised, open-label, superiority clinical trial conducted at multiple tertiary centres in China. The major eligibility criterion is the presence of insulinoma located in the head and neck of the pancreas in proximity (≤2 mm) to the main pancreatic duct. Blocked randomisation will be performed to allocate patients into the stent EN group and the direct EN group. Patients in the stent EN group will go through stent placement by the endoscopist within 24 hours before the EN surgery, whereas other patients will receive EN surgery directly. The primary outcome is the assessment of the superiority of stent placement in reducing POPF rate measured by the International Study Group of Pancreatic Surgery standard. Both interventions will be performed in an inpatient setting and regular follow-up will be performed. The primary outcome (POPF rate) will be tested for superiority with the X 2 test. The difference in secondary outcomes between the two groups will be analysed using appropriate tests. Ethics and dissemination The study has been approved by the Peking Union Medical College Hospital Institutional Review Board (K23C0195), Ruijin Hospital Ethics Committee (2023-314), Peking University First Hospital Ethics Committee (2024033-001), Institutional Review Board of Xuanwu Hospital of Capital Medical University (2023223-002), Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University (XJTU1AF2023LSK-473), Institutional Review Board of Tongji Medical College Tongji Hospital (TJ-IRB202402059), Ethics Committee of Tongji Medical College Union Hospital (2023-0929) and Shanghai Cancer Center Institutional Review Board (2309282-16). The results of the study will be published in an international peer-reviewed journal. Trial registration number NCT05523778.

Risk factors and prevention of postoperative pancreatic fistula after insulinoma enucleation:a retrospective study from a high-volume center

The Prognostic Value of External Vs Internal Pancreatic Duct Stents after Pancreaticoduodenectomy in Patients with FRS ≥ 4: a Retrospective Cohort Study

Efficacy of Pancreatic Duct Stenting Prior to Laparoscopic Pancreatic Tumor Enucleation

Analysis of Risk Factors for Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy

Preoperative pancreatic stent placement before the enucleation of insulinoma located in the head and neck of the pancreas in proximity to the main pancreatic duct: study protocol for a multicentre randomised clinical trial in Chinese tertiary medical centres

Risk Factors for Postoperative Pancreatic Fistula after Laparoscopic Distal Pancreatectomy Using Stapler Closure Technique from One Single Surgeon

Pancreatic Fistula after Pancreaticoduodenectomy: Risk Factors and Preventive Strategies

Mind the tributary of the canal: Are stents necessary for insulinoma enucleation in proximity to a prominent Duct of Santorini: A case report and literature review.

Preoperative Nutrition Support May Reduce the Prevalence of Postoperative Pancreatic Fistula after Open Pancreaticoduodenectomy in Patients with High Nutritional Risk Determined by NRS2002

Incidence and risk factors for postoperative pancreatic fistula in 2089 patients treated by radical gastrectomy: A prospective multicenter cohort study in China

Risk factors and medico-economic effect of pancreatic fistula after pancreaticoduodenectomy.

Use of a Pancreatic Fistula Risk Score System for Patients with Clinically Relevant Postoperative Pancreatic Fistula after Pancreaticoduodenectomy

Identifying the Risk Factors for Pancreatic Fistula after Laparoscopic Pancreaticoduodenectomy in Patients with Pancreatic Cancer

Prognostic Factors for Pancreatic Fistula Following Pancreaticoduodenectomy

Risk factor analysis for pancreatic fistula after pancreaticoduodenectomy for Vater′s ampullary carcinoma

Analysis of clinical risk factors with common operative complications after pancreatectomy

Application of Pancreaticojejunostomy Procedures Selection Strategy in Pancreaticoduodenectomy and Risk Factors Analysis of Pancreatic Fistula after Operation

Risk Factors of Pancreatic Fistula after Pancreaticoduodenectomy

Preoperative prediction of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy

Preoperative Ultrasound Radiomics for Predicting Clinically Relevant Postoperative Pancreatic Fistula after Pancreatectomy.

Predictive factors of postoperative pancreatic fistula after laparoscopic pancreatoduodenectomy